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Abstract 
A cDNA was isolated from rat brain by low stringency hybridization with the rat p opioid receptor cDNA. Sequence analysis of this clone indicated 
that it contains an open reading frame capable of encoding a 367 amino acid protein. The deduced amino acid sequence of this protein shows high 
degrees of homology to all three opioid receptors, p, K, and S, suggesting that it is a member of the opioid receptor gene family. RNA blot analysis 
detected high level expression of the receptor mRNA in the brain. Southern blot analysis suggests that it is a single-copy gene, and mapping studies 
localized the gene on mouse chromosome 2. Despite the high sequence homologies between this protein and the other opioid receptors, expression 
studies of this clone in COS-7 cells did not show binding to [‘I-Ildiprenorphine, a ligand that binds to the other three opioid receptors. Furthermore, 
co-expression of this receptor with a G protein-activated potassium channel in Xenopus oocytes did not show functional coupling upon stimulation 
with p, K and 6 agonists. Given the similar degrees of high homology to the ,u, K and 6 opioid receptors and the lack of apparent affinity for their 
ligands, this receptor does not appear to belong to any of the three known classes of opioid receptors. Rather, it represents a novel member of the 
opioid receptor gene family, not identified from previous pharmacological studies. 
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1. IIltroduction 
Exogenous opioid alkaloids and endogenous opioid 
peptides play a central role in mediating analgesia and 
many other physiological activities [l]. Opioids achieve 
their functions by interacting with three different types 
of opioid receptors, ,u, K and 6 [2]. It has been suggested 
by pharmacological studies that different subtypes may 
exist within each of the major types [3]. A member from 
each of the three opioid receptor classes has been cloned 
[48]. Sequence comparison of these three receptors re- 
veals highly conserved sequence similarities among 
them, reflecting the overlapping functions of these recep- 
tors [9]. In an effort to isolate other members of the 
opioid receptor gene family, we used the p receptor 
cDNA to screen a rat brain cDNA library under low 
stringency conditions. We report here the isolation of a 
cDNA clone with a high degree of sequence homology 
to the other three opioid receptors. 
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Abbreviations: RT, reverse transcription; PCR, polymerase chain 
reaction; DAMGG, [o-Ala2,MePhe4,GlyolS]enkephalim DPDPE, 
[o-Penz’]-enkephahn; U-50488, truer-(Q-3,4-dichloro-N-methyl-N-[2- 
(1 -pyrrolidinyl)-cyclohexyll-benzeneacetamide methanesulfonate; 
U-62066, (+)-(5a, 7a, 8/I)-3,4-ichloro-N-methyl-N-[2-(l-pyrrolidinyl)- 
1-oxaspiro[4.5]dec-8-yl]-benzeneacetamide esylate; Snap, synap- 
tosomal associated protein; Emvl5, ecotropic murine virus 15; Cd40, 
lymphocyte antigen 40. 
2. Experimental 
2.1. Library screening 
1.4 kb Hind111 cDNA fragment containing the complete protein 
coding region of the rat p opioid receptor [4] was used to screen a rat 
brain cDNA library under low stringency. Hybridization and the final 
wash were performed at 55’C using previously described conditions [4]. 
Sequence analysis of 24 isolated clones showed that four identical 
cDNA clones were similar to the three opioid receptors, ~1, Kand 6. One 
of four isolates was used for subsequent sequence analysis using double- 
stranded DNA and Sequenase version 2 (IJSB). Hydropathy analyses 
were performed and putative post-translational modification sites of 
the receptor protein were identified using the PCGENE program. Se- 
quence comparisons of this clone with other three opioid receptors, as 
well as other G protein-coupled receptors, were performed by the 
BLAST program available from NIH. 
2.2. RNA and DNA blot analysis 
A rat multiple tissue poly(A)’ RNA blot (Clontech) was used to study 
the tissue distribution of the putative opioid receptor under the conditions 
recommended by the company. The RNA blot was hybridized with a 
2.0 kb Hind111 fragment containing the entire protein encoding region 
of the putative opioid receptor clone. The final wash was performed in 
0.2 x SSC and 0.1% SDS at 55°C. For Southern analysis, 30 ,ug of rat 
genomic DNA was digested with BamHI, EcoRI and HindIII, respec- 
tively, and separated on a 0.8% agarose gel. The DNA was transferred 
to a Hybond-N membrane (Amersham) as described. The hybridization 
and wash condition was the same as for the RNA blotting. 
2.3. Chromosome mapping 
To map the receptor gene, two multilocus crosses were analyzed: 
@IFS/N or C58/J x M. m. musculw) x M. m. musculus [lo] and (NFSI 
N x M. spretus) x M. spretus or C58/J [ll]. Genomic DNAs from pa- 
rental and backcross mice were used in Southern blot hybridizations. 
and were probed with the receptor cDNA. Progeny of these crosses 
have also been typed for over 575 markers, including the Chr 2 markers 
Snap, Emvl5 and Cd40, typed as described previously [12,13]. 
2.4. Transient expression n CO97 cells 
A 2.0 kb Hind111 fragment encompassing the entire protein coding 
region of the putative opioid receptor was cloned downstream of the 
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human cytomegalovirus promoter in a mammalian cell expression vec- 
tor, pRC/CMV (Invitrogen). The recombinant plasmid was introduced 
into COS-7 cells by electroporation. Membrane preparation and bind- 
ing assays were performed as described [4]. One nanomolar 
[-‘H]diprenorphine was used in the binding assay. 
2.5. Expression and electrophysiological studies in Xenopus oocytes 
Xenopus oocytes were prepared as described [14]. The putative recep- 
tor mRNA was synthesized using T7 polymerase under the conditions 
described before [14]. The receptor mRNA was co-injected with a 
G protein-activated potassium channel mRNA into the oocytes as 
described [14]. Electrophysiological nalysis of the oocytes was carried 
out by a two-electrode voltage clamping method in a solution with high 
potassium concentration [14]. One micromolar of different opioid ag- 
onists was used for the oocyte recording assay. 
Rat putative opioid receptor MESLF 
3. Results and discussion 
A cDNA clone was isolated by screening a rat brain 
cDNA library under low stringency using the protein- 
coding region of the rat p opioid receptor cDNA [4] as 
the radiolabeled probe. Sequence analysis of the clone 
showed an open reading frame capable of encoding a 
protein with 367 amino acids. Hydropathy plot analysis 
showed that the protein contains seven hydrophobic do- 
mains, a structural signature common to most G protein- 
coupled receptors. Sequence comparison of this clone 
with the three cloned opioid receptors [4-81 suggests that 
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Fig. 1. Sequence alignment of the putative opioid receptor with three other opioid receptors. The ammo acids identical to the putative opioid receptor 
are marked by a dash (-). The seven putative hydrophobic transmembrane domains are underlined and labeled from TM1 to TM7. Gaps are 
introduced for alignment. Other symbols: (=), the conserved cysteine residues possibly involved with disulfide bond formation; (*), the conserved 
aspartic acid residues that may interact with the primary amine group found in ligands; (^), the potential N-linked glycosylation sites; (S), the putative 
protein kinase C sites; (o), the potential CAMP dependent protein kinase site; (#), the potential pahnitoylation site. The sequence of the putative opioid 
receptor has been submitted to Genbank with an accession umber of L28144. 
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Fig. 2. Homology relationships of the putative opioid receptor with 
three other opioid receptors. Amino acid homology was calculated by 
taking into consideration both identical and similar residues. Symbols 
used: ratmorl , the ratp opioid receptor [4,5]; ratkorl , the rat K receptor 
[9]; moudorl, the mouse S receptor [6,7]; ratxorl, the putative opioid 
receptor. 
it is closely related to these opioid receptors in structure. 
Fig. 1 illustrates the amino acid sequence alignment of 
this protein with the three opioid receptors. The overall 
similarity of this receptor with the three opioid receptors 
is around 65%, and a higher level of homology is found 
in some of the putative transmembrane domains (75- 
80%) as well as in the intracellular loop between trans- 
membrane domains 5 and 6 (-85%), a region that has 
been proposed to interact with G proteins [15]. 
Sequence comparison of this protein with other G 
protein-coupled receptors also detected homology to 
other receptors, including somatostatin receptors [16], 
angiotensin receptors [17] and formyl peptide receptor 
[ 181. However, the degree of similarity of this receptor to 
- 9.5 kb 
- 7.5 kb 
- 4.4 kb 
- 
- 
24 kb 
these non-opioid receptors is considerably lower (25- 
45%) than that to the three opioid receptors (65%), sug- 
gesting its close relationship to opioid receptors. It is 
noteworthy that this clone has an almost equal degree of 
similarity to other three opioid receptors. Fig. 2 shows 
the homology relationship between this receptor and 
each of the three opioid receptors as well as the homol- 
ogy relationships among the opioid receptors. This re- 
ceptor has a -65% similarity to each of the p, rc and 6 
receptors, whereas the similarity between any of the two 
opioid receptors is -70%. These homology values suggest 
that this receptor is likely to be a novel member of the 
opioid receptor gene family, and it does not appear to be 
a subtype within one the three receptor classes, i.e. p, K 
and 6. 
To determine the tissue distribution pattern of this 
novel receptor, RNA blot analysis was performed using 
RNA isolated from various rat tissues. Hybridization of 
the RNA blot with the protein coding region sequence 
of this receptor showed a high level expression in the 
brain (Fig. 3A). Three major transcription products were 
detected, with molecular sizes of about 10 kb, 7.5 kb and 
3.4 kb, respectively. The different sizes of mRNAs may 
result from differential splicing of the same primary tran- 
script, a phenomenon found in many other mammalian 
genes, including opioid receptors [6], or from multiple 
polyadenylation sites. 
Southern blot analysis was also performed. Rat 
genomic DNA was digested with HindIII, EcoRI or 
BarnHI and hybridized with the same radiolabeled probe 
23.1 kb 
9.4 kb 
6.6 kb 
) 4.4 kb 
Fig. 3. RNA tissue distribution and Southern blot analysis of the putative opioid receptor. (A) RNAs from eight different rat tissues are labeled above 
each lane. About 2 fig of poly(A)+ RNA was used for each tissue. The sizes of the RNA size marker are labeled on the left side; (B) genomic DNA 
Southern blot analysis. The restriction enzymes used to cut the rat genomic DNA are labeled above the corresponding lanes. lzDNA digested with 
Hind111 was used as the sine marker with the sizes labeled on the left side. 
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Fig. 4. Linkage of the putative opioid receptor gene Oprl with markers 
on Chr 2. (Top panel) Segregation of Oprlwith markers on Chr 2. Black 
squares represent heterozygous mice; open squares are homozygous 
mice. The numbers under each column represent the number of progeny 
in each of the two backcrosses with the indicated genotype. (Bottom 
panel) A partial Chr 2 linkage map indicating relative marker positions. 
Percent recombination and standard error were calculated from the 
total number of mice typed for each locus pair according to Green [25]. 
No double recombinants were observed in this data set. 
as used in the RNA blot analysis. As shown in Fig. 3B, 
the simple pattern of hybridizing bands in each of the 
restriction digestions suggests that the gene for this re- 
ceptor may be a single-copy one. It is noteworthy that 
the strongly hybridizing band in Hind111 is about 2 kb. 
Since that restriction analysis of the cDNA clone de- 
tected an internal Hind111 site in its 3’untranslated re- 
gion (data not shown) and that the protein coding region 
is about 1.1 kb, this result suggests that this receptor gene 
is most likely a compact one with small or no introns in 
its protein coding region. 
To determine the chromosome location of this recep- 
tor, the cDNA insert was used as a probe to analyze two 
multilocus crosses. Digestion with 13 different restriction 
enzymes failed to identify polymorphic fragments for the 
parental mice of our M. m. musculus cross [lo]. Digestion 
with EcoRI produced fragments of 7.8 and 6.6 kb in 
M. spretus and 19.4 and 16.0 in NFS/N. Progeny of the 
M. spretus cross were typed for inheritance of the poly- 
morphic fragments and the pattern of inheritance was 
compared with over 430 markers typed in this cross. As 
shown in Fig. 4, this gene, Oprl &ioid receptor like), 
maps to the distal region of Chromosome (Chr) 2 distal 
to Cd40. This region of Chr 2 is homologous to human 
chromosome 20 [19], suggesting a human map location 
for this gene. 
Examination of this region of Chr 2 identified two 
recessive mutations, wasted (wst) and lethal spotting (Is). 
Homozygous wasted mice have tremor and uncoordi- 
nated body movements at 20 days of age, and they de- 
velop progressive paralysis leading to death before 30 
days. Homozygous lethal spotting mice have white spot- 
ting and die in the third week of life from megacolon with 
deficiency of intrinsic ganglion cells in the lower colon. 
Since opioids have effects on both the nervous system 
and gastrointestinal functions, the close proximity of 
Oprl to wst and IS warrants further investigation of the 
potential role of the putative opioid receptor in these 
mutant phenotypes. 
In an attempt to determine the pharmacological pro- 
file of this novel receptor, we expressed the cDNA clone 
in both COS-7 cells and Xenopus oocytes. A Hind111 
fragment encompassing the entire protein coding region 
of this receptor was subcloned in pRC/CMV vector 
downstream from the cytomegalovirus promoter, and 
this construct was used in transient expression studies in 
COS-7 cells. As positive controls for COS-7 expression, 
the rat jf opioid receptor cDNA in the same vector [4] 
was used in parallel transfection (data not shown). Bind- 
ing assays using the COS-7 cell membranes transfected 
with this receptor clone and [3H]diprenorphine, a ligand 
with high affinity for the three opioid receptors [20], did 
not detect any specific binding (data not shown), while 
the positive control showed good expression of the rat 
p opioid receptor. Furthermore, mRNA of this clone 
was synthesized by in vitro transcription and co-injected 
into Xenopus oocytes with the mRNA for a G protein- 
activated potassium channel [21,22]. It has been shown 
that this inwardly rectifying potassium channel is ftmc- 
tionally coupled to both 6 and p opioid receptors [14,221. 
However, no potassium conductance was induced by 
stimulation of the oocytes with a broad range of opioid 
agonists, including DAMGO, morphine, DPDPE, 
U-50488 and U-62066 (data not shown). In parallel ex- 
periments, mRNA of the p opioid receptor was used as 
a positive control and showed high-level expression. 
These results further suggest that this receptor may not 
belong to any of the three opioid receptors. It is unlikely 
that this receptor gene is a pseudo-gene, since it is tran- 
scribed into RNA (Fig. 3A) and we isolated the clone 
from a cDNA library. During the preparation of this 
manuscript, a report appeared about the isolation of a 
human cDNA clone encoding a novel member of the 
opioid receptor family [23]. This clone is most likely a 
human homologue of the one reported here, since the 
two clones share 94% identity at the amino acid sequence 
level. 
Thus, we have isolated a novel seven-helix receptor 
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cDNA. The high degrees of sequence homology with all 
three types of opioid receptors and the lack of apparent 
affinity for many opioid ligands suggest that it encodes 
a novel member of the opioid receptor gene family, with 
previously unknown pharmacological characteristics. 
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Note added in proof 
Fukuda et al. [24] reported the isolation of a rat cDNA clone that is identical to the one reported here. 
